Deal Watch: United Therapeutics Looks To Extend PAH Dominance With Respira's Combo Product

13 Apr 2017

• By Joseph Haas, Ian Haydock, Lubna Ahmed, and Jung Won Shin

United will finance clinical development of drug/inhaler device combo with Respira. Takeda offloads more mature products to its joint venture with Teva, and signs a microbiome partnership with Finch Therapeutics.

Deal Watch: United Therapeutics Looks To Extend PAH Dominance With Respira's Combo Product

More from Deals

More from Business